News

Tesla shares fall as CEO Elon Musk says he plans to form a new political party after reigniting a feud with President Donald ...
Stock futures edged lower Monday morning as President Trump threatened an additional 10% tariff on countries supporting the ...
S&P 500 E-Mini futures (ESU25) are up +0.08%, and September Nasdaq 100 E-Mini futures (NQU25) are up +0.17% this morning as ...
Bengaluru: India's French connection is growing stronger. French IT services firm Capgemini, which has more than half of its ...
William Blair downgraded WNS Holdings (WNS) to Market Perform from Outperform without a price target after the company agreed to be acquired by ...
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of WNS (Holdings) Limited (NYSE: WNS) to Capgemini for $76.50 per share is fair to WNS shareholders.
The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...
The transaction, which offers $76.50 per WNS share, reflects a 17% premium over WNS' most recent closing price and has received unanimous approval from both companies' boards. Capgemini expects the ...
The French consulting and technology group is offering $76.5 per WNS share, a premium of 17% to the stock’s closing price on ...
Capgemini's shares fell over 5% following its $3.3 billion acquisition of BPO firm WNS, amid investor worries about the impact of AI on the BPO sector.